[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Myriad Genetics Inc (MYGN)

Myriad Genetics Inc (MYGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 576,133
  • Shares Outstanding, K 94,448
  • Annual Sales, $ 824,500 K
  • Annual Income, $ -365,900 K
  • EBIT $ -64 M
  • EBITDA $ 309 M
  • 60-Month Beta 1.64
  • Price/Sales 0.67
  • Price/Cash Flow 1.56
  • Price/Book 1.64

Options Overview Details

View History
  • Implied Volatility 77.74% (-66.04%)
  • Historical Volatility 67.18%
  • IV Percentile 11%
  • IV Rank 4.65%
  • IV High 586.89% on 02/19/26
  • IV Low 52.89% on 08/12/25
  • Expected Move (DTE 7) 0.26 (4.19%)
  • Put/Call Vol Ratio 0.07
  • Today's Volume 60
  • Volume Avg (30-Day) 52
  • Put/Call OI Ratio 0.19
  • Today's Open Interest 2,108
  • Open Int (30-Day) 2,003
  • Expected Range 5.83 to 6.34

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 10 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $-0.08
  • Number of Estimates 1
  • High Estimate $-0.08
  • Low Estimate $-0.08
  • Prior Year $-0.06
  • Growth Rate Est. (year over year) -33.33%

Price Performance

See More
Period Period Low Period High Performance
1-Month
4.19 +45.11%
on 06/15/26
6.26 -2.80%
on 07/06/26
+1.65 (+37.25%)
since 06/10/26
3-Month
3.53 +72.24%
on 05/19/26
6.26 -2.80%
on 07/06/26
+1.73 (+39.77%)
since 04/10/26
52-Week
3.53 +72.24%
on 05/19/26
8.59 -29.22%
on 10/16/25
+0.58 (+10.55%)
since 07/10/25

Most Recent Stories

More News
New Large-Scale Meta-Analysis Demonstrates Strong Prognostic Performance of Myriad’s Prolaris® Biopsy Test in Localized Prostate Cancer

SALT LAKE CITY, July 02, 2026 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announces newly published data from the...

MYGN : 5.89 (-3.44%)
1 Unpopular Stock That Should Get More Attention and 2 We Find Risky

1 Unpopular Stock That Should Get More Attention and 2 We Find Risky

KO : 83.28 (+0.79%)
RH : 167.59 (-0.44%)
MYGN : 5.89 (-3.44%)
Spotting Winners: Myriad Genetics (NASDAQ:MYGN) And Therapeutics Stocks In Q1

Spotting Winners: Myriad Genetics (NASDAQ:MYGN) And Therapeutics Stocks In Q1

MYGN : 5.89 (-3.44%)
Why Is Myriad Genetics (MYGN) Stock Rocketing Higher Today

Why Is Myriad Genetics (MYGN) Stock Rocketing Higher Today

MYGN : 5.89 (-3.44%)
Myriad Genetics Expands Availability of Precise MRDâ„¢ for Colorectal, Renal and Breast Cancers, Supported by New Publication

SALT LAKE CITY, June 23, 2026 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. , (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announces expanded availability of Precise...

MYGN : 5.89 (-3.44%)
1 Cash-Burning Stock with Promising Prospects and 2 Facing Headwinds

1 Cash-Burning Stock with Promising Prospects and 2 Facing Headwinds

GH : 159.63 (-2.71%)
MYGN : 5.89 (-3.44%)
COHR : 318.72 (-2.60%)
3 High-Flying Stocks We’re Skeptical Of

3 High-Flying Stocks We’re Skeptical Of

HLT : 339.92 (+0.67%)
LSTR : 209.57 (+0.90%)
MYGN : 5.89 (-3.44%)
Myriad Genetics Names Raj Jampa as New Chief Technology Officer

SALT LAKE CITY, June 02, 2026 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. , (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, announces today the appointment of Raj Jampa...

MYGN : 5.89 (-3.44%)
Myriad Genetics Highlights Data Showing Broad Clinical Utility of Precise MRD Assay at 2026 ASCO Annual Meeting

SALT LAKE CITY, May 27, 2026 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. , (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, announces it will share data demonstrating the...

MYGN : 5.89 (-3.44%)
Myriad Genetics Launches Prolaris® + AI, the First Prostate Cancer Test to Combine Genomics and Digital Pathology Artificial Intelligence (AI)

SALT LAKE CITY, May 26, 2026 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. , (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, announces the launch of the Prolaris + AI Test...

MYGN : 5.89 (-3.44%)

Business Summary

Myriad Genetics employs a number of proprietary technologies to target the genetic basis of human diseases and the role these genes might play in the onset, progression and treatment of the respective diseases. The company has more than 10 proprietary molecular diagnostic products in market. It has made...

See More

Key Turning Points

3rd Resistance Point 6.61
2nd Resistance Point 6.39
1st Resistance Point 6.24
Last Price 5.89
1st Support Level 5.88
2nd Support Level 5.66
3rd Support Level 5.51

See More

52-Week High 8.59
Fibonacci 61.8% 6.66
Fibonacci 50% 6.06
Last Price 5.89
Fibonacci 38.2% 5.46
52-Week Low 3.53

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.